Market Insights The spinal muscular atrophy medicine market is projected to grow from USD 980.6 million in 2020 to USD 2,085.4 million by 2026 at a CAGR of 13.4% during the forecast period. What is Spinal Muscular Atrophy (SMA)? Spinal Muscular Atrophy (SMA) is a very rare genetic disorder that affects the part of the central nervous system that...